SCHEMBL25570684

SCHEMBL25570684

Cc1ccccc1-c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3cncc(-c5ccc(-c6ccccc6)cc5)c34)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP3 O14638 1/20 0.38
ENPP1 P22413 1/20 0.38
CSNK2A2 P19784 1/20 0.36
CSNK2B P67870 1/20 0.36
LMNA P02545 1/20 0.35
NPC1 O15118 4/20 0.35
RAB9A P51151 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
TSHR P16473 3/20 0.35
HPGD P15428 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
HTT P42858 1/20 0.34
KDM4E B2RXH2 1/20 0.34
AHR P35869 1/20 0.34
VSIR Q9H7M9 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
TRPA1 O75762 1/20 0.34
DPP4 P27487 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25570433 0.99 ENPP3 (0.39) ENPP3ENPP1CSNK2A2CSNK2BLMNA
SCHEMBL25570912 0.96 VSIR (0.36) ENPP3ENPP1CSNK2A2CSNK2BLMNA
SCHEMBL24523398 0.92 PRKCZ (0.36) LMNANPC1RAB9ASMN1; SMN2TSHR
SCHEMBL24523421 0.92 PRKCZ (0.36) LMNANPC1RAB9ASMN1; SMN2TSHR
SCHEMBL24523399 0.92 PRKCZ (0.36) LMNANPC1RAB9ASMN1; SMN2TSHR
SCHEMBL25570465 0.88 ENPP3 (0.41) ENPP3ENPP1LMNANPC1RAB9A
SCHEMBL25570436 0.88 MAPT (0.41) ENPP3LMNANPC1RAB9ASMN1; SMN2
SCHEMBL25570688 0.88 MAPT (0.41) ENPP3LMNANPC1RAB9ASMN1; SMN2
SCHEMBL25570650 0.87 ENPP3 (0.40) ENPP3ENPP1LMNANPC1RAB9A
SCHEMBL25570200 0.87 ENPP3 (0.42) ENPP3ENPP1LMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167097-A1 HETEROCYCLIC COMPOUND HAVING CYANO-SUBSTITUTION Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167097-A1 HETEROCYCLIC COMPOUND HAVING CYANO-SUBSTITUTION KCNH1, MCM4, MCM2 ENPP3 1767/4885ENPP1 705/4885CSNK2A2 867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.